Clinical Trial Update: PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study [NA]

View source ↗

Summary

A pilot PET imaging trial using the 124I-labeled humanized antibody 3F8 to visualize solid tumors, including melanoma, neuroblastoma, and sarcoma; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Neuroblastoma
• Sarcoma

Drugs mentioned

• 124I-hu3F8 (humanized anti-GD2 antibody (hu3F8))

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma, Neuroblastoma | NA | Status: ACTIVE_NOT_RECRUITING